# FDA recall D-1302-2020

> **QuVa Pharma, Inc.** · Class II · drug recall initiated 2020-05-28.

## Product

oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07

## Reason for recall

Subpotent drug - Product did not contain drug.

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-1302-2020
- **Recalling firm:** QuVa Pharma, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-05-28
- **Report date:** 2020-06-17
- **Termination date:** 2022-01-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sugar Land, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1302-2020

## Citation

> AI Analytics. FDA recall D-1302-2020. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-1302-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*